These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7501441)

  • 1. Binding of phosphorothioate oligodeoxynucleotides to basic fibroblast growth factor, recombinant soluble CD4, laminin and fibronectin is P-chirality independent.
    Benimetskaya L; Tonkinson JL; Koziolkiewicz M; Karwowski B; Guga P; Zeltser R; Stec W; Stein CA
    Nucleic Acids Res; 1995 Nov; 23(21):4239-45. PubMed ID: 7501441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple mechanisms may contribute to the cellular anti-adhesive effects of phosphorothioate oligodeoxynucleotides.
    Khaled Z; Benimetskaya L; Zeltser R; Khan T; Sharma HW; Narayanan R; Stein CA
    Nucleic Acids Res; 1996 Feb; 24(4):737-45. PubMed ID: 8604318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorothioate oligodeoxynucleotides bind to basic fibroblast growth factor, inhibit its binding to cell surface receptors, and remove it from low affinity binding sites on extracellular matrix.
    Guvakova MA; Yakubov LA; Vlodavsky I; Tonkinson JL; Stein CA
    J Biol Chem; 1995 Feb; 270(6):2620-7. PubMed ID: 7852327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polydeoxyguanine motifs in a 12-mer phosphorothioate oligodeoxynucleotide augment binding to the v3 loop of HIV-1 gp120 and potency of HIV-1 inhibition independency of G-tetrad formation.
    Lederman S; Sullivan G; Benimetskaya L; Lowy I; Land K; Khaled Z; Cleary AM; Yakubov L; Stein CA
    Antisense Nucleic Acid Drug Dev; 1996; 6(4):281-9. PubMed ID: 9012864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oligodeoxynucleotides interact with recombinant CD4 at multiple sites.
    Yakubov L; Khaled Z; Zhang LM; Truneh A; Vlassov V; Stein CA
    J Biol Chem; 1993 Sep; 268(25):18818-23. PubMed ID: 7689560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of phosphorothioate modification of oligodeoxynucleotides on specific protein binding.
    Brown DA; Kang SH; Gryaznov SM; DeDionisio L; Heidenreich O; Sullivan S; Xu X; Nerenberg MI
    J Biol Chem; 1994 Oct; 269(43):26801-5. PubMed ID: 7929417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of phosphorothioate modifications on the ability of GTn oligodeoxynucleotides to specifically recognize single-stranded DNA-binding proteins and to affect human cancer cellular growth.
    Morassutti C; Scaggiante B; Dapas B; Xodo L; Tell G; Quadrifoglio F
    Biochimie; 1999 Dec; 81(12):1115-22. PubMed ID: 10607406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequence confirmation of synthetic phosphorothioate oligodeoxynucleotides using Sanger sequencing reactions in combination with mass spectrometry.
    Lu DD; Chen SH; Zhang W; Liang QD; Wang SQ
    Anal Biochem; 2005 Oct; 345(1):81-9. PubMed ID: 16102718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of high affinity basic fibroblast growth factor binding by oligonucleotides.
    Fennewald SM; Rando RF
    J Biol Chem; 1995 Sep; 270(37):21718-21. PubMed ID: 7665590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorothioate oligodeoxynucleotides inhibit basic fibroblast growth factor-induced angiogenesis in vitro and in vivo.
    Kitajima I; Unoki K; Maruyama I
    Antisense Nucleic Acid Drug Dev; 1999 Apr; 9(2):233-9. PubMed ID: 10355829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-surface perturbations of the epidermal growth factor and vascular endothelial growth factor receptors by phosphorothioate oligodeoxynucleotides.
    Rockwell P; O'Connor WJ; King K; Goldstein NI; Zhang LM; Stein CA
    Proc Natl Acad Sci U S A; 1997 Jun; 94(12):6523-8. PubMed ID: 9177251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorothioate oligonucleotide-directed triple helix formation.
    Hacia JG; Wold BJ; Dervan PB
    Biochemistry; 1994 May; 33(18):5367-9. PubMed ID: 8180158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular pharmacology and protein binding of phosphoromonothioate and phosphorodithioate oligodeoxynucleotides: a comparative study.
    Tonkinson JL; Guvakova M; Khaled Z; Lee J; Yakubov L; Marshall WS; Caruthers MH; Stein CA
    Antisense Res Dev; 1994; 4(4):269-78. PubMed ID: 7537561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antisense binding enhanced by tertiary interactions: binding of phosphorothioate and N3'-->P5' phosphoramidate hexanucleotides to the catalytic core of a group I ribozyme from the mammalian pathogen Pneumocystis carinii.
    Testa SM; Gryaznov SM; Turner DH
    Biochemistry; 1998 Jun; 37(26):9379-85. PubMed ID: 9649319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro selection of phosphorothiolated aptamers.
    Jhaveri S; Olwin B; Ellington AD
    Bioorg Med Chem Lett; 1998 Sep; 8(17):2285-90. PubMed ID: 9873529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of some properties of oligodeoxynucleotides containing 4'-thio-2'-deoxynucleotides: duplex hybridization and nuclease sensitivity.
    Jones GD; Lesnik EA; Owens SR; Risen LM; Walker RT
    Nucleic Acids Res; 1996 Nov; 24(21):4117-22. PubMed ID: 8932360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetics and thermodynamics of i-DNA formation: phosphodiester versus modified oligodeoxynucleotides.
    Mergny JL; Lacroix L
    Nucleic Acids Res; 1998 Nov; 26(21):4797-803. PubMed ID: 9776737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards rational design of antisense DNA: molecular modelling of phosphorothioate DNA analogues.
    Jaroszewski JW; Syi JL; Maizel J; Cohen JS
    Anticancer Drug Des; 1992 Jun; 7(3):253-62. PubMed ID: 1610482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorothioate oligodeoxynucleotides: large-scale synthesis and analysis, impurity characterization, and the effects of phosphorus stereochemistry.
    Fearon KL; Hirschbein BL; Chiu CY; Quijano MR; Zon G
    Ciba Found Symp; 1997; 209():19-31; discussion 31-7. PubMed ID: 9383566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5'-Cholesteryl-phosphorothioate oligodeoxynucleotides: potent inhibition of methotrexate transport and antagonism of methotrexate toxicity in cells containing the reduced-folate carrier.
    Henderson GB; Stein CA
    Nucleic Acids Res; 1995 Sep; 23(18):3726-31. PubMed ID: 7479003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.